As of 1:34pm ET
| -0.015 / -1.04%|
The 6 analysts offering 12-month price forecasts for Arrowhead Pharmaceuticals Inc have a median target of 11.00, with a high estimate of 15.00 and a low estimate of 5.00. The median estimate represents a +671.93% increase from the last price of 1.43.
The current consensus among 6 polled investment analysts is to Buy stock in Arrowhead Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.